JaySGiriMDMPH
Cardiology • Philadelphia, PAInterventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine
Interventional Cardiologist, Hospital of the University of Pennsylvania
Dr. Giri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
East Pavilion, 2nd Floor
Philadelphia, PA 19104Phone+1 215-615-4949
Summary
- Dr. Jay Giri is a cardiologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania, Pennsylvania Hospital, and Philadelphia Veterans Affairs Medical Center. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice 13 years. He specializes in interventional cardiology, peripheral endovascular interventional cardiology, and vascular medicine and is experienced in valvular heart disease, interventional cardiology, cardiac catheterization, peripheral vascular disease, and minimally invasive cardiac surgery.
Education & Training
Massachusetts General HospitalFellowship, Interventional Cardiology, 2011 - 2012
University of Pennsylvania Health SystemFellowship, Interventional Cardiology, 2010 - 2011- University of Pennsylvania Health SystemFellowship, Cardiovascular Disease, 2007 - 2010
- Massachusetts General HospitalResidency, Internal Medicine, 2004 - 2007
Northwestern University The Feinberg School of MedicineClass of 2004
Certifications & Licensure
PA State Medical License 2007 - 2024
MA State Medical License 2011 - 2013
TN State Medical License 2012 - 2013- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 105 citationsAortic Stenosis: Pathophysiology, Diagnosis, and TherapyJessica Joseph, Syed Yaseen Naqvi, Jay Giri, Sheldon Goldberg
The American Journal of Medicine. 2017-03-01 - 40 citationsStatin therapy for reduction of cardiovascular and limb-related events in critical limb ischemia: A systematic review and meta-analysis:Damianos G. Kokkinidis, Angelos Arfaras-Melainis, Stefanos Giannopoulos, Ioannis Katsaros, Omar Jawaid
Vascular Medicine. 2020-01-22 - 17 citationsSelf-Expanding Valve System for Treatment of Native Aortic Regurgitation by Transcatheter Aortic Valve Implantation (from the STS/ACC TVT Registry).Saif Anwaruddin, Nimesh D. Desai, Wilson Y. Szeto, James B. Hermiller, Paul Sorajja
The American Journal of Cardiology. 2019-09-01
Journal Articles
- Performance of Hospitals When Assessing Disease-Based Mortality Compared with Procedural Mortality for Patients with Acute Myocardial InfarctionAshwin S Nathan, Rishi K Wadhera, Deepak L Bhatt, Daniel M Kolansky, Ajay J Kirtane, Robert W Yeh, Tracy Y Wang, Jay Giri, JAMA Cardiology
- Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016Daniel M Kolansky, Taisei Kobayashi, Peter W Groeneveld, Jay Giri, JAMA
- Treatment of Submassive and Massive Pulmonary Embolism: A Clinical Practice Survey from the Second Annual Meeting of the Pulmonary Embolism Response Team ConsortiumKenneth Rosenfield, Geoffrey D Barnes, Michael R Jaff, Thomas M Todoran, Christopher Kabrhel, Rachel P Rosovsky, Jay Giri, Journal of Thrombosis and Thrombolysis
Authored Content
- Prasugrel or Ticagrelor for Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Does It Matter?May 2018
- Is It Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation on Anticoagulation?April 2018
Press Mentions
ELEGANCE Registry Studies Drug-Eluting Device Treatment of PAD in Underrepresented Minorities and WomenNovember 5th, 2024- Inari Medical Announces PEERLESS II, a Randomized Controlled Trial Evaluating Clinical Outcomes of the FlowTriever® System vs. Anticoagulation in Pulmonary Embolism PatientsMay 22nd, 2023
- New Statement Suggests More Patients May Benefit From Surgery for Pulmonary EmbolismJanuary 23rd, 2023
- Join now to see all
External Links
- Leonard Davis Institutehttps://ldi.upenn.edu/expert/jay-giri-md-mph
- CAVOQERhttp://www.med.upenn.edu/cavoqer/about.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
